In the progression from acute injury to chronic disability, Peripheral Sensitization represents the first major shift in the nervous system’s functional state. While nociception is the normal physiological response to a threat, peripheral sensitization is a pathological state of increased responsiveness. For the board-certified physician, understanding this “inflammatory soup” is essential for explaining why a patient’s surgical site remains hypersensitive long after the initial incision has closed.

---

1. The Definition of Hypersensitivity

To understand sensitization, one must master two clinical terms that appear on every pain medicine exam:

• Hyperalgesia: An increased response to a stimulus that is normally painful. (e.g., a pinprick feeling like a knife stab).
• Allodynia: Pain due to a stimulus that does not normally provoke pain. (e.g., the touch of a bedsheet feeling agonizing).
• Primary Hyperalgesia: Occurs at the site of the injury and is primarily driven by the peripheral mechanisms discussed in this article.

---

2. The “Inflammatory Soup”: The Chemical Drivers

When tissue is damaged, it releases a cocktail of chemicals often referred to as the “inflammatory soup.” This soup doesn’t just activate nociceptors; it fundamentally changes their threshold for firing.

The Key Ingredients

• Prostaglandins (PGE2): Released from damaged cell membranes via the cyclooxygenase (COX) pathway. They do not cause pain directly but “prime” the nociceptor, making it much more sensitive to other chemicals.
• Bradykinin: One of the most potent pain-producing substances known. it is released from plasma precursors following tissue damage and directly activates nociceptors.
• Histamine and Serotonin: Released from mast cells and platelets. They contribute to the “triple response of Lewis” (redness, wheal, and flare).
• Hydrogen Ions (H+) and ATP: Tissue ischemia and cell death lead to an acidic environment. Protons activate ASICs (Acid-Sensing Ion Channels) on the nerve endings.
• Substance P and CGRP (Calcitonin Gene-Related Peptide): These are released by the nerve itself in a process called Antidromic Conduction. They cause vasodilation and further mast cell degranulation, a phenomenon known as Neurogenic Inflammation.

---

3. Molecular Mechanisms: Lowering the Threshold

How do these chemicals actually change the “firing” of a nerve? The magic happens at the Transduction level, specifically involving the TRPV1 receptor (the “capsaicin receptor”).

1. Phosphorylation: Chemicals like Bradykinin and Prostaglandins activate intracellular kinases (Protein Kinase C and A).
2. Ion Channel Modification: These kinases “phosphorylate” the TRPV1 channels and voltage-gated sodium channels (Nav 1.7, 1.8, and 1.9).
3. The Result: The threshold for opening these channels is lowered. A stimulus that previously wouldn’t have reached the “trigger point” (threshold) for an action potential now causes the nerve to fire repeatedly.

---

4. Silent Nociceptors: The “Sleeping” Giants

Under normal conditions, a significant portion of C-fibers are “silent”—meaning they do not respond to even intense mechanical or thermal stimuli. However, when bathed in the “inflammatory soup” for a prolonged period, these silent nociceptors “wake up” and begin to fire. This massive increase in the total amount of sensory input to the spinal cord is a primary driver of the next stage of pain: Central Sensitization.

---

5. Clinical Application and Pharmacological Targets

Understanding the “soup” dictates how we treat acute and subacute pain:

• NSAIDs: The most direct intervention; they block the COX enzyme, preventing the production of prostaglandins, thereby “de-sensitizing” the nociceptor.
• Corticosteroids: These work “upstream” of NSAIDs by inhibiting Phospholipase A2, preventing the release of arachidonic acid altogether.
• Ice/Cryotherapy: Causes vasoconstriction, which limits the arrival of inflammatory mediators and slows the conduction velocity of sensitized nerves.
• Topical Capsaicin: Initially causes a burning sensation by activating TRPV1, but with chronic use, it leads to the “defunctionalization” of the nociceptor terminals, effectively exhausting the supply of Substance P.

---

6. High-Yield Board “Fast Facts”

• Primary Hyperalgesia: Driven by peripheral sensitization at the site of injury.
• Neurogenic Inflammation: Driven by the release of Substance P and CGRP from the nociceptors themselves.
• TRPV1 Receptor: The primary transducer for thermal and chemical pain; its threshold is lowered during sensitization.
• Silent Nociceptors: Inactive fibers that become active only in the presence of inflammation.
• Sodium Channels (Nav 1.7): A high-yield target for genetic studies; a mutation in SCN9A (which encodes Nav 1.7) can lead to “Congenital Insensitivity to Pain.”